Maternal care startup Promom has secured ₹30 crore in its first institutional funding round led by Fireside Ventures. The Noida-based company, which produces feeding aids like breast pumps and sterilizers, will use the capital to scale its product range and distribution. This funding highlights the growing investor focus on specialized consumer healthcare products for the Indian market.
Noida-based maternal and baby care startup Promom has successfully raised ₹30 crore in its first institutional funding round. The investment was led by Fireside Ventures, a venture capital firm known for its focus on consumer brands. Founded in 2023 by Manas Tripathi, Anavi Kalia, and Aditya Srivastava, the company operates in the specialized segment of feeding products for new mothers.
Strategic Focus on Local Market Needs
Promom was created to address what its founders identified as a lack of products specifically designed for the Indian body type and lifestyle. According to the company, existing global products often failed to account for variations in breast and nipple sizes or specific lactation flows common among Indian mothers. By focusing on these localized design requirements, the startup developed a suite of products including breast pumps, bottle warmers, sterilizers, and formula makers. Since beginning commercial operations in January 2024, the company reports that its flagship breast pump has been used by over 1.5 lakh mothers.
Sales Strategy and Distribution
The company utilizes a direct-to-consumer model through its own website, complemented by listings on major Indian e-commerce platforms such as Flipkart, Amazon, and FirstCry. A key part of its distribution strategy involves institutional partnerships, notably with the Cloudnine Hospital chain, where its products are available across more than 29 locations. This hybrid approach helps the brand reach mothers at both the prenatal and postnatal stages of care.
Growth Plans and Future Monitorables
With the fresh infusion of ₹30 crore, Promom aims to accelerate its expansion. The company plans to dedicate these funds to three primary areas: deepening its product portfolio, increasing investment in research and development, and widening its distribution footprint. Additionally, the company is preparing to open a new office in the Delhi-NCR region to support its growing operations.
For investors observing the consumer healthcare space, the primary monitorables will be the company's ability to maintain product quality as it scales, the cost-effectiveness of its customer acquisition strategy, and how it competes against established global and domestic brands in the competitive baby care segment. Future updates on the performance of new product categories and any potential further rounds of funding will be important indicators of the brand's long-term sustainability in this niche market.